Solara Active Pharma Sciences Limited (NSE:SOLARA)

NSE:SOLARA Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	84.4	87.3	463.8	1,977	560.4
Cash & Short-Term Investments	60.7	84.4	87.3	463.8	1,977	560.4
Cash Growth	-6.04%	-3.32%	-81.18%	-76.54%	252.77%	-25.99%
Accounts Receivable	-	3,485	5,370	4,897	4,839	2,265
Other Receivables	-	481.5	375	619.7	572.8	325.5
Receivables	-	3,970	6,071	6,032	5,428	3,114
Inventory	-	3,597	5,581	5,756	2,950	2,797
Prepaid Expenses	-	114.2	99.9	84.1	156.5	73.2
Other Current Assets	-	241.8	36.2	57.2	65.2	174.8
Total Current Assets	-	8,008	11,875	12,393	10,576	6,720
Property, Plant & Equipment	-	11,142	11,591	11,374	9,992	9,516
Long-Term Investments	-	17	17	4.2	4.2	3.2
Goodwill	-	3,651	3,651	3,651	3,651	3,651
Other Intangible Assets	-	425.6	543.5	679.4	799.8	922.8
Long-Term Deferred Tax Assets	-	-	785.6	551.4	256.1	0.7
Other Long-Term Assets	-	266.4	529.9	794	855	717.2
Total Assets	-	23,510	28,993	29,450	26,136	21,535
Accounts Payable	-	3,130	3,059	2,760	3,093	2,161
Accrued Expenses	-	98.4	92.8	85.9	61.7	67.1
Short-Term Debt	-	6,873	6,488	6,099	3,609	3,538
Current Portion of Long-Term Debt	-	1,333	1,173	1,316	912	1,203
Current Portion of Leases	-	5.1	5.5	21	20.5	24.1
Current Income Taxes Payable	-	0.1	0.1	3.3	1.4	8.4
Current Unearned Revenue	-	157.3	74.3	179.8	152.7	196.4
Other Current Liabilities	-	832	119.5	169	37.4	100.9
Total Current Liabilities	-	12,429	11,011	10,634	7,887	7,299
Long-Term Debt	-	1,058	2,351	2,830	1,548	2,328
Long-Term Leases	-	116.1	111.5	107	117.7	127.6
Long-Term Unearned Revenue	-	-	-	231.3	284.9	427.4
Long-Term Deferred Tax Liabilities	-	-	-	-	-	118.3
Other Long-Term Liabilities	-	105	110.9	99.1	117.8	112
Total Liabilities	-	14,144	13,968	14,178	10,208	10,633
Common Stock	-	360	360	360	359.3	268.5
Additional Paid-In Capital	-	12,160	12,160	12,160	12,117	8,206
Retained Earnings	-	-3,175	2,493	2,737	3,389	1,397
Comprehensive Income & Other	-	-6	-11.3	-8.8	20.3	988.4
Total Common Equity	10,860	9,339	15,002	15,249	15,885	10,859
Minority Interest	-	26.7	22.4	23.1	42.4	42.9
Shareholders' Equity	10,887	9,366	15,025	15,272	15,928	10,902
Total Liabilities & Equity	-	23,510	28,993	29,450	26,136	21,535
Total Debt	8,400	9,385	10,129	10,374	6,207	7,220
Net Cash (Debt)	-8,339	-9,301	-10,041	-9,910	-4,230	-6,660
Net Cash Per Share	-323.22	-258.38	-278.95	-275.72	-123.29	-248.81
Filing Date Shares Outstanding	39.85	36	36	36	35.93	26.86
Total Common Shares Outstanding	39.85	36	36	36	35.93	26.86
Working Capital	-	-4,421	864.1	1,759	2,689	-579
Book Value Per Share	344.38	259.45	416.77	423.62	442.12	404.37
Tangible Book Value	6,851	5,263	10,808	10,918	11,435	6,286
Tangible Book Value Per Share	217.23	146.20	300.25	303.32	318.25	234.06
Land	-	782.6	782.6	782.5	773	637.8
Buildings	-	3,283	3,172	2,918	2,727	2,477
Machinery	-	9,032	8,948	8,064	7,441	6,905
Construction In Progress	-	2,564	2,385	2,387	879.8	404.7
Leasehold Improvements	-	37.1	159.2	150	146.7	145.6

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.